Safety and Efficacy of Autologous or Donor-derived CD19 CAR-T Treatment in Relapsed B Acute Lymphocytic Leukemia after Allo-HSCT

被引：0
|
作者：
Zhang, Xian [1 ]
Lu, Xin-An [2 ]
Xiong, Min [1 ]
Yang, Jun-Fang [1 ]
Zhang, Jian-Ping [1 ]
Zhou, Xiao-Su [1 ]
He, Ting [2 ]
Lu, Pei-Hua [1 ]
机构：
[1] Hebei Yanda Ludaopei Hosp, Langfang, Peoples R China
[2] Immuno China Pharmaceut Co Ltd, Beijing, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O144
引用
收藏
页码：122 / 123
页数：2
相关论文
共 50 条
  • [41] Donor-derived CD19 CAR-T Cells versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL After Allogeneic Hematopoietic Stem Cell Transplantation
    Tan, Xu
    Wang, Xiao-qi
    Zhang, Cheng
    Zhao, Xian-lan
    Yao, Han
    Chen, Guo
    Ma, Ying-ying
    Wen, Qin
    Gao, Lei
    Gao, Li
    Kong, Pei-yan
    Shen, Yan
    Zhang, Xi
    Lou, Shi-feng
    CURRENT MEDICAL SCIENCE, 2023, 43 (04) : 733 - 740
  • [42] Donor-derived CD19 CAR-T Cells versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL After Allogeneic Hematopoietic Stem Cell Transplantation
    Xu Tan
    Xiao-qi Wang
    Cheng Zhang
    Xian-lan Zhao
    Han Yao
    Guo Chen
    Ying-ying Ma
    Qin Wen
    Lei Gao
    Li Gao
    Pei-yan Kong
    Yan Shen
    Xi Zhang
    Shi-feng Lou
    Current Medical Science, 2023, 43 : 733 - 740
  • [43] CD22 Gating for Flow Cytometric Analysis in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia after CD19 CAR-T Therapy
    Yu, Xinjian
    Li, Pan
    Feng, Heyuan
    Kang, Jian
    Zheng, Xichang
    Zhang, Yunmei
    Yang, Wenhong
    Wu, Tong
    Liu, Shuangyou
    BLOOD, 2020, 136
  • [44] FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells
    Galli, Eugenio
    Frioni, Filippo
    Malara, Tanja
    Attardi, Enrico
    Bellesi, Silvia
    Hohaus, Stefan
    Sica, Simona
    Sora, Federica
    Chiusolo, Patrizia
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [45] Evolution and Proliferation of CD7 CAR-T Cells Compared to CD19 CAR-T Cells Therapies for Acute Leukemia
    Zhang, Xian
    Zhang, Gailing
    Li, Wenqian
    Qiu, Liyuan
    Wang, Dongchu
    Yang, Junfang
    Li, Jingjing
    Lu, Peihua
    BLOOD, 2021, 138
  • [46] Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CART therapy
    An, Lihong
    Lin, Yuehui
    Deng, Biping
    Yin, Zhichao
    Zhao, Defeng
    Ling, Zhuojun
    Wu, Tong
    Zhao, Yongqiang
    Chang, Alex H.
    Tong, Chunrong
    Liu, Shuangyou
    BMC CANCER, 2022, 22 (01)
  • [47] Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL
    Qiu, Yan
    Wan, Chao-Ling
    Xu, Ming-Zhu
    Zhou, Hai-Xia
    Liu, Mei-Jing
    Gong, Wen-Jie
    Kang, Li-Qing
    Sun, Ai-Ning
    Yu, Lei
    Wu, De-Pei
    Qian, Chong-Sheng
    Xue, Sheng-Li
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [48] Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL
    Yan Qiu
    Chao-Ling Wan
    Ming-Zhu Xu
    Hai-Xia Zhou
    Mei-Jing Liu
    Wen-Jie Gong
    Li-Qing Kang
    Ai-Ning Sun
    Lei Yu
    De-Pei Wu
    Chong-Sheng Qian
    Sheng-Li Xue
    Blood Cancer Journal, 13
  • [49] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
    Gu, Runxia
    Liu, Fang
    Zou, Dehui
    Xu, Yingxi
    Lu, Yang
    Liu, Bingcheng
    Liu, Wei
    Chen, Xiaojuan
    Liu, Kaiqi
    Guo, Ye
    Gong, Xiaoyuan
    Lv, Rui
    Chen, Xia
    Zhou, Chunlin
    Zhong, Mengjun
    Wang, Huijun
    Wei, Hui
    Mi, Yingchang
    Qiu, Lugui
    Lv, Lulu
    Wang, Min
    Wang, Ying
    Zhu, Xiaofan
    Wang, Jianxiang
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [50] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
    Runxia Gu
    Fang Liu
    Dehui Zou
    Yingxi Xu
    Yang Lu
    Bingcheng Liu
    Wei Liu
    Xiaojuan Chen
    Kaiqi Liu
    Ye Guo
    Xiaoyuan Gong
    Rui Lv
    Xia Chen
    Chunlin Zhou
    Mengjun Zhong
    Huijun Wang
    Hui Wei
    Yingchang Mi
    Lugui Qiu
    Lulu Lv
    Min Wang
    Ying Wang
    Xiaofan Zhu
    Jianxiang Wang
    Journal of Hematology & Oncology, 13
12345